Wednesday, September 19, 2018

UBX To Report Phase I Data In Q1, NVTA On Watch, NTGN Faces Busy Year Ahead

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

from RTT - Biotech https://ift.tt/2MMAUB9
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)